EWTX vs PTCT: stock comparison and AI forecast
Edgewise Therapeutics, Inc. (EWTX) and Ptc Therapeutics, Inc. (PTCT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
EWTX Edgewise Therapeutics, Inc.
- Price
- $45.04 +26.6% · 6M
- Market Cap
- $4.89B
- P/E Ratio
- 5.4x
- Size
- mid-cap
- AI Forecast
PTCT Ptc Therapeutics, Inc.
- Price
- $65.44 +1.5% · 6M
- Market Cap
- $5.47B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- PTCT is 1.1 times larger than EWTX by market capitalization ($5.47B against $4.89B).
- Over the last six months EWTX returned +26.6% and PTCT +1.5%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | EWTX | PTCT |
|---|---|---|
| Market Cap | $4.89B | $5.47B |
| P/E Ratio | 5.36x | – |
| P/B Ratio | 3.00x | – |
| EPS | $8.41 | $-2.25 |
| Book Value/Share | $15.03 | – |
| Revenue/Share | – | $13.83 |
| FCF/Share | $-1.86 | $0.02 |
Profitability & Margins
| Metric | EWTX | PTCT |
|---|---|---|
| ROE | 61.8% | – |
| ROA | 56.7% | -3.3% |
| ROIC | -13.3% | 6.1% |
| Operating Margin | – | 12.8% |
| Net Margin | – | -9.2% |
| EBT Margin | – | -7.4% |
| Tax Rate | – | -24.5% |
Financial Health
| Metric | EWTX | PTCT |
|---|---|---|
| Current Ratio | 12.30x | 3.27x |
| Quick Ratio | – | 3.13x |
| D/E Ratio | 0.09x | – |
| Financial Leverage | 1.09x | – |
| Interest Coverage | – | 7.3x |
| Working Capital | $1.63B | $1.76B |
Cash Flow
| Metric | EWTX | PTCT |
|---|---|---|
| Operating Cash Flow | -$202M | $10M |
| Free Cash Flow | -$202M | $2M |
| Capital Spending | -$380K | -$8M |
| OCF Growth YoY | – | -98.5% |
| FCF Growth YoY | – | -99.7% |
| FCF/Sales | – | 0.2% |
| CapEx/Sales | – | 0.7% |
Operational Efficiency
| Metric | EWTX | PTCT |
|---|---|---|
| Asset Turnover | – | 0.36x |
| Receivables Turnover | – | 4.8x |
| Fixed Assets Turnover | – | 23.4x |
| Days Sales Outstanding | – | 75 days |
Income Statement
| Metric | EWTX | PTCT |
|---|---|---|
| Total Revenue | – | $1.16B |
| Operating Income | -$218M | $148M |
| Net Income | $1.01B | -$106M |
| R&D Expense | $165M | $438M |
| SG&A Expense | – | $344M |
Dividend & Shareholder Information
| Metric | EWTX | PTCT |
|---|---|---|
| Shares Outstanding | 109M | 84M |
| Net Income Growth | – | -114.1% |
| EPS Growth | – | -126.3% |
EWTX vs PTCT: stock comparison and AI forecast
Which is bigger, EWTX or PTCT?
PTCT is 1.1 times larger than EWTX by market capitalization ($5.47B against $4.89B).
Which stock performed better over the last six months, EWTX or PTCT?
Over the last six months EWTX returned +26.6% and PTCT +1.5%.
Which one does Intratio's AI model rank higher, EWTX or PTCT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.